ADMP
Adamis Pharmaceuticals Prices $45 Million Share Offering; Shares Down 17%
Adamis Pharmaceuticals (ADMP) said Friday it priced an underwritten public offering of about 40.5 million common shares at $1.11 each for proceeds of about $45 million.
The company granted the underwriters a 30-day option to purchase up to about 6.1 million additional shares at the same offering price. Adamis said it expects the offering to close on Feb. 2 and proceeds will be used for general working capital.
Shares were down 17% in morning trading.
Price: 1.16, Change: -0.24, Percent Change: -17.14
Adamis Pharmaceuticals (ADMP) said Friday it priced an underwritten public offering of about 40.5 million common shares at $1.11 each for proceeds of about $45 million.
The company granted the underwriters a 30-day option to purchase up to about 6.1 million additional shares at the same offering price. Adamis said it expects the offering to close on Feb. 2 and proceeds will be used for general working capital.
Shares were down 17% in morning trading.
Price: 1.16, Change: -0.24, Percent Change: -17.14
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.